A consultative approach helps reps position sterilization as a strategy for safety, compliance and efficiency.
Proper sterilization remains one of the most critical – yet often overlooked – elements of infection prevention in physician offices, according to Tracy Timmerman, Director of Marketing, Medical, at Midmark Corporation.
“Proper sterilization is foundational because it is a line of defense between contaminated instruments and the patient,” Timmerman said. “Even with strong protocols upstream such as cleaning, disinfection and personal protective equipment (PPE), failure at the sterilization process directly exposes patients to infection risk.”
In outpatient settings, sterilization gaps are rarely caused by a single issue. Instead, they stem from a combination of process, staffing and environmental challenges. Time-constrained staff, decentralized responsibilities and limited visibility into behind-the-scenes workflows all contribute to inconsistencies.
“Sterilization breakdowns in outpatient settings are rarely due to a single issue,” Timmerman said. “They’re typically the result of small gaps across process, people and environment.”
Common errors include overloaded sterilizers, incorrect packaging and non-standardized processes. Documentation and traceability also remain persistent weak points, making it difficult for practices to prove compliance or respond to a failed cycle. Staff turnover and inconsistent training further increase variability.
Timmerman noted that physical layout is another frequently overlooked factor. “Many offices don’t have a dedicated sterilization area with clear separation between dirty and clean zones, increasing the risk of cross-contamination,” she said. She added that “the absence of medical-grade cabinetry and surfaces can further limit a team’s ability to maintain an organized, compliant workflow.”
“The consequences are significant – increased infection risk, compliance issues, liability exposure and loss of patient trust,” Timmerman said.
For distributor sales reps, the takeaway extends beyond equipment. “Sterilization isn’t just about the sterilizer. Even the best equipment can’t compensate for gaps in workflow or environment,” she said.
Autoclaves and the sales opportunity
Autoclaves have evolved significantly in recent years, shifting from standalone devices to more integrated, workflow-driven systems.
Much of that evolution centers on compliance. “Features like automatic cycle recordkeeping, device reminders and automated mechanical monitoring and chemical indicator reporting help practices stay audit-ready and reduce documentation errors, one of the most common sterilization gaps,” Timmerman noted.
Ease of use has also improved, particularly for busy physician offices managing staff turnover. Touchscreen interfaces, step-by-step prompts and preset cycles aligned with CDC and AAMI guidelines help standardize processes and reduce staff-dependent variability.
Efficiency gains are another key advancement. “Faster, more automated cycles, along with features like real-time status indicators and audible alerts, allow staff to manage instrument flow more effectively without constantly monitoring the unit,” Timmerman said. At the same time, newer systems are designed for durability, with longer cycle life and fewer service interruptions.
For distributor sales reps, sterilization equipment represents a critical – but often under-discussed – category. “Sterilization can be overlooked and under-discussed because it operates in the background,” Timmerman said, noting many practices rely on aging equipment or inconsistent processes.
That creates opportunity. “By asking the right questions and evaluating the full sterilization workflow, not just the sterilizer, they can uncover gaps that impact efficiency, compliance and risk,” she said.
Key questions to uncover hidden gaps
For distributor sales reps, assessing a practice’s sterilization readiness starts with understanding the full workflow – not just the equipment – according to Timmerman. Reps should ask questions that uncover how sterilization is actually being managed day-to-day.
From a workflow and volume standpoint, Timmerman recommends asking, “How many instrument loads do you run per day?” and “Do you ever experience delays due to instrument turnaround?” to identify bottlenecks and capacity issues.
On the compliance side, documentation and monitoring are critical. Questions such as “How are you documenting cycles?” and “How often are biological indicators used, and how are results handled?” can reveal gaps in verification and recordkeeping.
Equipment age and maintenance are also key indicators of risk. “How old is your sterilizer?” and “When was it last serviced or validated?” can help reps evaluate reliability and the potential for failure.
Staffing and training should not be overlooked. “Who is responsible for sterilization?” and “How are new team members trained?” can point to inconsistencies that may impact outcomes.
Finally, risk preparedness is essential. Asking “What happens if a cycle fails?” helps determine whether a practice has clear protocols in place.
“Ultimately, these questions help identify hidden gaps not just in equipment, but in processes, training and compliance that many practices may not recognize on their own,” Timmerman said.
Reframing the sterilization conversation
Distributor sales reps can elevate sterilization discussions by focusing on outcomes – not just equipment – Timmerman noted.
“The key is to shift the conversation from ‘buying a sterilizer’ to protecting the practice,” she said. “Reps can frame sterilization as a strategic tool for risk reduction and operational excellence, not just a piece of equipment.”
That shift starts by anchoring conversations in what matters most to physician offices:
- Risk mitigation: Reduces infection risk, liability and compliance exposure.
- Operational efficiency: Speeds instrument turnaround and eases staff workload.
- Standardization: Ensures every cycle is done correctly, every time.
- Documentation and defensibility: Provides proof of compliance for audits or inspections.
- Patient trust and reputation: Supports the safety and experience patients expect.
By leading with these outcomes, reps can move beyond transactional selling and into a more consultative role.
“Strong reps anchor the discussion in these outcomes – safer patients and staff, fewer risks, smoother workflows – making sterilization a meaningful, consultative conversation rather than a simple product sale,” Timmerman said.